Methods and compositions for treating neoplasms
The present invention comprises the periodic administration of a solution of neuraminidase to a patient with a neoplasm until the neoplasm has receded. The administration of the solution of neuraminidase can be administered by subcutaneous injection, intramuscular injection, intravenous injection, nasal administration, sublingual administration or transdermal administration. The present invention is effective in treating a wide variety of neoplasms.
1. A method for treating a human with leukemia, comprising administering to the human with leukemia a therapeutically effective amount of neuraminidase between approximately 10 −2 and 10 −8 mg per dose.
2. The method of claim 1 , wherein the neuraminidase is dissolved in a phenol-saline solution.
3. The method of claim 1 , wherein the neuraminidase is administered by subcutaneous injection, intramuscular injection, intravenous injection, nasal administration, sublingual administration or transdermal administration.
4. The method of claim 3 , wherein the neuraminidase is administered sublingually.
5. The method of claim 1 wherein the neuraminidase is administered between approximately 10 −3 and 10 −7 mg per dose.
6. The method of claim 1 wherein the neuraminidase is administered at approximately 10 −4 mg per dose.
7. The method of claim 1 wherein the neuraminidase is administered up to about 8 times per day.
8. The methods of claim 1 wherein the neuraminidase is administered between 2-7 times per day.
9. The method of claim 1 wherein the neuraminidase is administered for 4 times per day.
10. The method of claim 1 wherein on the first day of treatment, the neuraminidase is administered 5 times in the first hour followed by 3-4 more times evenly throughout the first day and then 2-7 times per day afterwards until the neoplasm is no longer detectable.